TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus

H. Daiko; H. Hara; H. Ogawa; K. Hori; J. Mizusawa; S. Ozawa; M. Takagi; M. Tanaka; H. Baba; Y. Shirakawa; M. Tsuda; S. Nakagawa; H. Takeuchi; T. Abe; Y. Ito; T. Kojima; T. Kadota; H. Fukuda; K. Kato; Y. Kitagawa

doi:10.1093/annonc/mdy282.162

TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus

H. Daiko, H. Hara, H. Ogawa, K. Hori, J. Mizusawa, S. Ozawa, M. Takagi, M. Tanaka, H. Baba, Y. Shirakawa, M. Tsuda, S. Nakagawa, H. Takeuchi, T. Abe, Y. Ito, T. Kojima, T. Kadota, H. Fukuda, K. Kato, Y. Kitagawa

Department of Surgery (General and Gastroenterological Surgery)

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	viii266
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy282.162
Publication status	Published - 2018 Oct 1

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy282.162

Cite this

Daiko, H., Hara, H., Ogawa, H., Hori, K., Mizusawa, J., Ozawa, S., Takagi, M., Tanaka, M., Baba, H., Shirakawa, Y., Tsuda, M., Nakagawa, S., Takeuchi, H., Abe, T., Ito, Y., Kojima, T., Kadota, T., Fukuda, H., Kato, K., & Kitagawa, Y. (2018). TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii266. https://doi.org/10.1093/annonc/mdy282.162

TRIANgLE study (JCOG1510) : A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. / Daiko, H.; Hara, H.; Ogawa, H.; Hori, K.; Mizusawa, J.; Ozawa, S.; Takagi, M.; Tanaka, M.; Baba, H.; Shirakawa, Y.; Tsuda, M.; Nakagawa, S.; Takeuchi, H.; Abe, T.; Ito, Y.; Kojima, T.; Kadota, T.; Fukuda, H.; Kato, K.; Kitagawa, Y.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii266.

Research output: Contribution to journal › Article

Daiko, H, Hara, H, Ogawa, H, Hori, K, Mizusawa, J, Ozawa, S, Takagi, M, Tanaka, M, Baba, H, Shirakawa, Y, Tsuda, M, Nakagawa, S, Takeuchi, H, Abe, T, Ito, Y, Kojima, T, Kadota, T, Fukuda, H, Kato, K & Kitagawa, Y 2018, 'TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii266. https://doi.org/10.1093/annonc/mdy282.162

Daiko H, Hara H, Ogawa H, Hori K, Mizusawa J, Ozawa S et al. TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii266. https://doi.org/10.1093/annonc/mdy282.162

Daiko, H. ; Hara, H. ; Ogawa, H. ; Hori, K. ; Mizusawa, J. ; Ozawa, S. ; Takagi, M. ; Tanaka, M. ; Baba, H. ; Shirakawa, Y. ; Tsuda, M. ; Nakagawa, S. ; Takeuchi, H. ; Abe, T. ; Ito, Y. ; Kojima, T. ; Kadota, T. ; Fukuda, H. ; Kato, K. ; Kitagawa, Y. / TRIANgLE study (JCOG1510) : A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii266.

@article{4e4de3bd0c8f40f689dba0f4255eb35e,

title = "TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus",

author = "H. Daiko and H. Hara and H. Ogawa and K. Hori and J. Mizusawa and S. Ozawa and M. Takagi and M. Tanaka and H. Baba and Y. Shirakawa and M. Tsuda and S. Nakagawa and H. Takeuchi and T. Abe and Y. Ito and T. Kojima and T. Kadota and H. Fukuda and K. Kato and Y. Kitagawa",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy282.162",

language = "English",

volume = "29",

pages = "viii266",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - TRIANgLE study (JCOG1510)

T2 - A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus

AU - Daiko, H.

AU - Hara, H.

AU - Ogawa, H.

AU - Hori, K.

AU - Mizusawa, J.

AU - Ozawa, S.

AU - Takagi, M.

AU - Tanaka, M.

AU - Baba, H.

AU - Shirakawa, Y.

AU - Tsuda, M.

AU - Nakagawa, S.

AU - Takeuchi, H.

AU - Abe, T.

AU - Ito, Y.

AU - Kojima, T.

AU - Kadota, T.

AU - Fukuda, H.

AU - Kato, K.

AU - Kitagawa, Y.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081527806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081527806&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy282.162

DO - 10.1093/annonc/mdy282.162

M3 - Article

C2 - 32136607

VL - 29

SP - viii266

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -